Skeletal Dysplasia Account Manager - Washington, D.C.

BridgeBio
Boston, Washington DC, Pittsburgh, New York, New Jersey
Workplace: RemoteFull timeUSD 155,000 - 210,000 annuallyFunction: Customer Success & Account ManagementExperience: 8-10 yearsEducation: bachelorsSkills: ["Leadership","Communication","Analytical skills","Resilience","Relationship building"]

Drive the commercial launch of Infigratinib for achondroplasia by building and executing a Northeast territory business plan. You’ll develop partnerships with geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multidisciplinary clinic teams to meet sales goals. Use deep product and disease expertise to lead compliant, clinically relevant discussions, anticipate territory challenges using sales data, and collaborate across BridgeBio to expand advocacy and ensure “One Bridge” execution.

Loading

Loading job details...

Preparing the role view and application actions.

FursaFursa
BridgeBio
BridgeBio
2 months ago

Skeletal Dysplasia Account Manager - Washington, D.C.

✓ Verified Job

Canonical indexed version, validated from employer's careers page.

Source: Company careers pageValidated by: Fursa AI
Last checked: 4 hours agoStatus: Live

Job Summary

Drive the commercial launch of Infigratinib for achondroplasia by building and executing a Northeast territory business plan. You’ll develop partnerships with geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multidisciplinary clinic teams to meet sales goals. Use deep product and disease expertise to lead compliant, clinically relevant discussions, anticipate territory challenges using sales data, and collaborate across BridgeBio to expand advocacy and ensure “One Bridge” execution.
Location: Boston, Washington DC, Pittsburgh, New York, New Jersey
Workplace: Remote
Employment Type: Full time
Job Function: Customer Success & Account Management
Seniority: Mid level

Key Responsibilities

  • •Develop and execute a territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and skeletal dysplasia clinic teams to meet/exceed sales goals.
  • •Demonstrate deep expertise in Infigratinib and achondroplasia; engage HCPs in clinically relevant, compliant discussions.
  • •Use sales and target data to identify growth opportunities and address territory challenges proactively.
  • •Partner compliantly with field medical, field reimbursement, family account teams, and the HUB to maximize customer and family satisfaction.
  • •Build and maintain relationships with KOLs with Marketing and Medical Affairs to expand advocacy for Infigratinib and BridgeBio while operating with a “One Bridge” mindset.
Travel: Extensive travel

Pay and Benefits

Salary: USD 155,000 - 210,000 annually
Equity and Bonus:Equity
Perks:Health InsuranceDentalVision401kEquityEsppHsaFsaParental LeavePaid LeaveAnnual Bonus

Key Requirements

  • •8–10 years in pharmaceutical/biotech with 4+ years in rare/genetic disease or skeletal dysplasia; achondroplasia or pediatric rare disease experience preferred.
  • •BS/BA required (MBA a plus).
  • •Proven product/indication launch experience and ability to create demand through disease-state and stakeholder education.
  • •Demonstrated account management success analyzing complex accounts and driving implementation to measurable impact.
  • •Willingness to travel extensively; strong leadership, communication, AI fluency, and integrity with compliance focus.
Experience:8-10 yearsBiotechPharmaceuticalRare diseaseGenetic diseaseSkeletal dysplasiaPediatric rare disease
Education:Bachelor's
Skills:LeadershipCommunicationAnalytical skillsResilienceRelationship building
Languages:English
Tech Stack:AI

Company Brief

BridgeBio
Develops medicines for patients with genetic diseases by advancing targeted therapeutics from discovery through clinical development and commercialization, focusing on genetically defined diseases with high unmet medical need.
Industry: Biotech
Company Size: Large (251 to 1,000 employees)
Growth: Public Company
Valuation: Public Company (Market Cap in USD)
Funding: IPO / Publicly Listed
Headquarters: Palo Alto, United States
Founded: 2015
WebsiteLinkedIn